Mopon, Genoveva P.

HRN: 22-99-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
CEFTAZIDIME 1GM (VIAL)
05/01/2023
05/08/2023
IV
1gm
Q8H
CAP-MR
Waiting Final Action 
05/08/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/08/2023
05/14/2023
IV
1.5g
Q6h
CAP MR
Waiting Final Action 
05/09/2023
CLARITHROMYCIN 500MG (CAP)
05/09/2023
05/16/2023
ORAL
500mg
Q12h
CAP-MR
Waiting Final Action 
05/10/2023
CEFTRIAXONE 1G (VIAL)
05/10/2023
05/16/2023
IV
2g
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: